HIGHLIGHTS
- who: Ke Zhou from the Trust, United Kingdom Medical University of Vienna, Austria have published the paper: Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: On the whole, our meta-analysis showed that patients with low PLR had better OS and PFS, as well as higher ORR and DCR when receiving immunotherapy in advanced lung cancer especially for advanced NSCLC.
- how: The authors collected OS/PFS data from each . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.